Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneic mouse tumour cells

International Journal of Cancer. Journal International Du Cancer
R A GrahamJoyce Taylor-Papadimitriou

Abstract

Much interest is currently being shown in immunotherapy as a treatment for cancer since several tumour-associated antigens have been identified and the genes encoding them cloned. One such molecule is the tumour-associated human MUC1 gene product. In this report we describe tumour rejection studies in a C57B1 murine model system with syngeneic MUC1-expressing tumour cells designed to examine the efficacy of MUC1 cDNA as an immunogen. Intra-muscular immunisation with 100 microgram MUC1 cDNA 3 times at 3-weekly intervals resulted in tumour protection in approximately 80% of mice. Tumour protection was dose-dependent, with 50-100 microgram being the most effective dose. Both humoral and cell-mediated MUC1-specific immune responses were detected. Anti-MUC1 antibodies were detected after immunisation with DNA alone, indicating that the injected DNA was expressed. Humoral immune responses did not correlate with tumour rejection. Tumour challenge with syngeneic tumour cells expressing MUC1 appeared to be a pre-requisite for the generation of MUC1-specific cytotoxic T lymphocytes.

References

Sep 1, 1992·Human Molecular Genetics·J A WolffA Jani
Jan 1, 1992·Biotherapy·O J Finn
Feb 1, 1992·Human Gene Therapy·S JiaoJ A Wolff
Mar 23, 1990·Science·J A WolffP L Felgner
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M HareuveniR Lathe
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P GunningL Kedes
Oct 15, 1989·International Journal of Cancer. Journal International Du Cancer·J BurchellT Duhig
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D L BarndO J Finn
Aug 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L X ShenI Tinoco
Jun 14, 1995·Gene·K DhingraG N Hortobagyi
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·E RazM A Yankauckas

❮ Previous
Next ❯

Citations

Jun 11, 2010·Glycobiology·Gianfranco PiccoJoy Burchell
Apr 28, 2010·Expert Opinion on Biological Therapy·Shifang YuanWei Han
Jul 5, 2005·Expert Opinion on Investigational Drugs·D W Miles, J Taylor-Papadimitriou
Jun 5, 2004·Expert Review of Vaccines·Leona A Holmberg, Brenda Sandmaier
Nov 14, 1998·Annals of Medicine·D J LeeD A Carson
Dec 26, 2009·Journal of Ovarian Research·Subhash C ChauhanMeena Jaggi
Oct 9, 1998·Viral Immunology·L Kucerova
Feb 14, 1998·International Journal of Cancer. Journal International Du Cancer·J SamuelB M Longenecker
Feb 8, 2005·Cancer Immunology, Immunotherapy : CII·Karl G KohlgrafMichael A Hollingsworth
Nov 26, 2010·International Journal of Cancer. Journal International Du Cancer·Julia A ColemanJoyce Taylor-Papadimitriou
Sep 1, 1996·Cancer Metastasis Reviews·P F Searle, L S Young
Feb 25, 2005·International Journal of Cancer. Journal International Du Cancer·Isabel CorreaJoyce Taylor-Papdimitriou
Jan 10, 2008·Bioprocess and Biosystems Engineering·Tina KubitzkiStephan Lütz
Mar 16, 2004·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jilin Yi, Geng Tian
Aug 25, 2005·Expert Review of Vaccines·Bruce Acres, Jean-Marc Limacher
Sep 23, 2000·Gene Therapy·A RughettiM Nuti
Feb 3, 2006·Expert Review of Vaccines·Christian A Petrulio, Howard L Kaufman
Sep 5, 2008·Expert Review of Vaccines·Choon-Kit Tang, Vasso Apostolopoulos
Jun 25, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Shifang YuanTing Wang
Mar 27, 2003·BJU International·D P ScholfieldM C Bishop
Nov 24, 2020·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Takashi KurashigeHirofumi Maruyama
Nov 26, 1999·Biochimica Et Biophysica Acta·J Taylor-PapadimitriouM Dalziel
Nov 9, 2007·Biochimica Et Biophysica Acta·Mads Agervig Tarp, Henrik Clausen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Qian ChenEthan M Shevach
The Journal of Immunology : Official Journal of the American Association of Immunologists
Yi ZhangYiwei Chu
The Journal of Immunology : Official Journal of the American Association of Immunologists
Mukanthu H NyirendaBruno Gran
The Journal of Immunology : Official Journal of the American Association of Immunologists
Hans-Heinrich ObergDaniela Wesch
© 2021 Meta ULC. All rights reserved